DNA discovery confirms new clinical biomarker in predicting breast cancer risk

CancerDr James Flanagan – Senior Lecturer in the Division of Cancer has been involved in research looking into identifying a new biomarker in the blood that could help identify more women at a high risk of breast cancer.

In a prospective study, researchers from Imperial College London and the Human Genetics Foundation (HuGeF) in Torino, Italy, have concluded that DNA methylation levels in blood cells are associated with breast cancer risk, and could be used to identify women at high risk of developing the disease.

Full article

Leave a Reply

Your email address will not be published. Required fields are marked *